Association of Bone Mineral Density and Dementia: The Rotterdam Study
Authors
Affiliations
Background And Objectives: Low bone mineral density (BMD) and dementia commonly co-occur in older individuals, with bone loss accelerating in patients with dementia due to physical inactivity and poor nutrition. However, uncertainty persists over the extent to which bone loss already exists before onset of dementia. Therefore, we investigated how dementia risk was affected by BMD at various skeletal regions in community-dwelling older adults.
Methods: In a prospective population-based cohort study, BMD at the femoral neck, lumbar spine, and total body and the trabecular bone score (TBS) were obtained using dual-energy X-ray absorptiometry in 3,651 participants free from dementia between 2002 and 2005. Persons at risk of dementia were followed up until January 1, 2020. For analyses of the association between BMD at baseline and the risk of incident dementia, we used Cox proportional hazards regression analyses, adjusting for age, sex, educational attainment, physical activity, smoking status, body mass index, systolic and diastolic blood pressure, cholesterol level, high-density lipoprotein cholesterol, history of comorbidities (stroke and diabetes mellitus), and genotype.
Results: Among the 3,651 participants (median age 72.3 ± 10.0 years, 57.9% women), 688 (18.8%) developed incident dementia during a median of 11.1 years, of whom 528 (76.7%) developed Alzheimer disease (AD). During the whole follow-up period, participants with lower BMD at the femoral neck (per SD decrease) were more likely to develop all-cause dementia (hazard ratio [HR] 1.12, 95% CI 1.02-1.23) and AD (HR 1.14, 95% CI 1.02-1.28). Within the first 10 years after baseline, the risk of dementia was greatest for groups with the lowest tertile of BMD (femoral neck BMD, HR 2.03; 95% CI 1.39-2.96; total body BMD, HR 1.42; 95% CI 1.01-2.02; and TBS, HR 1.59; 95% CI 1.11-2.28).
Discussion: In conclusion, participants with low femoral neck and total body BMD and low TBS were more likely to develop dementia. Further studies should focus on the predictive ability of BMD for dementia.
Hiri-O-Tappa P, Lawongsa K, Kengpanich S, Srisuwan P Cureus. 2024; 16(6):e63511.
PMID: 39081449 PMC: 11288215. DOI: 10.7759/cureus.63511.
Xu S, Wen S, Yang Y, He J, Yang H, Qu Y Neurology. 2024; 103(4):e209659.
PMID: 39047204 PMC: 11314951. DOI: 10.1212/WNL.0000000000209659.
The flavonoid fisetin reduces multiple physiological risk factors for dementia.
Maher P Neurochem Int. 2024; 178:105805.
PMID: 39004102 PMC: 11304624. DOI: 10.1016/j.neuint.2024.105805.
Crosstalk between bone and brain in Alzheimer's disease: Mechanisms, applications, and perspectives.
Liu Z, Liu M, Xiong Y, Wang Y, Bu X Alzheimers Dement. 2024; 20(8):5720-5739.
PMID: 38824621 PMC: 11350061. DOI: 10.1002/alz.13864.
The multi-faceted nature of age-associated osteoporosis.
Smit A, Meijer O, Winter E Bone Rep. 2024; 20:101750.
PMID: 38566930 PMC: 10985042. DOI: 10.1016/j.bonr.2024.101750.